Skip to main content
Log in

Efficacy and Safety of Intravenous S-Adenosyl-L-Methionine Therapy in the Management of Intrahepatic Cholestasis of Pregnancy

  • Published:
Drug Investigation Aims and scope Submit manuscript

Summary

Intrahepatic cholestasis of pregnancy (ICP) requires the earliest possible treatment, as it increases the risk of premature delivery and fetal distress. Furthermore, the severity of pruritus in ICP may interfere with the mother’s well-being. We present results of a trial involving an additional 55 cases of ICP (mean age 29 years), who received SAMe 800 mg/day intravenously at the onset of ICP, for 10 to 30 days. Clinical assessment of pruritus and measurements of serum total bile salts (STBS), serum total and conjugated bilirubin (STB, SCB), serum alkaline phosphatase (SAP), and aspartate and alanine aminotransferases (AST, ALT) were performed before and after therapy. SAMe treatment significantly (p < 0.01) decreased STBS (18.3 ± 3.4 vs 23.1 ± 3.4 μmol/L), SCB (7.8 ± 0.8 vs 10.7 ± 1.2 μmol/L), SAP (4.7 ± 0.2 vs 6.1 ± 0.3 μkat/L), AST (0.9 ± 0.1 vs 2.0 ± 0.2 μkat/L), and ALT (1.6 ± 0.1 vs 2.9 ± 0.2 μkat/L) levels compared with basal values. At baseline, most patients exhibited normal STB and therefore no significant change in this parameter was recorded after therapy. Pruritus was significantly improved after SAMe treatment, and was reduced in 15 patients and had disappeared in 40 patients. No adverse reactions were observed. There were no cases of premature labour, and all newborns had normal Apgar scores (mean 8.2) and were of normal weight for gestational age. These results further support the use of SAMe therapy in ICP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arias IM. Mechanisms and consequences of ion transport in the liver. In Popper M & Schaffner F (Eds) Progress in liver diseases. Vol. 8, pp. 145–159, Grune & Stratton, New York, 1986

    Google Scholar 

  • Bell KM, Plon L, Bunney WE, Potkin SG. S-adenosylmethionine treatment of depression: a controlled clinical trial. American Journal of Psychiatry 145: 1110–1114, 1988

    PubMed  CAS  Google Scholar 

  • Bergasa NV, Jones A. Management of the pruritus of cholestasis: potential role of opiate antagonists. American Journal of Gastroenterology 86: 659–670, 1991

    Google Scholar 

  • Boelsterli UA, Rakhit G, Balazs T. Modulation by S-adenosyl-L-methionine of hepatic Na+, K+-ATPase, membrane fluidity, and bile flow in rats with ethynylestradiol-induced cholestasis. Hepatology 3: 12–17, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bonfirraro G, Chieffi O, Quinti R, et al. S-Adenosyl-L-methionine (SAMe)-induced amelioration of intrahepatic cholestasis of pregnancy. Results of an open study. Drug Investigation 2: 125–128, 1990

    Google Scholar 

  • Boyer JL. Treatment of intrahepatic cholestasis. In Rodés J, Arroyo V (Eds) Therapy in liver diseases, pp. 73–82, Ediciones Doyma, Barcelona, 1991

    Google Scholar 

  • Chawla RK, Bonkovsky HL, Galambos JT. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease. Drugs 40: 98–110, 1990

    Article  PubMed  Google Scholar 

  • Combes B, Shore GM, Cunningham FG, et al. Serum γ-gluta-myltranspeptidase activity in viral hepatitis: suppression in pregnancy and by birth control pills. Gastroenterology 72: 271–274, 1977

    PubMed  CAS  Google Scholar 

  • Espinoza J, Barnafi L, Schnaidt E. The effect of phenobarbital on intrahepatic cholestasis of pregnancy. American Journal of Obstetrics and Gynecology 119: 234–238, 1974

    PubMed  CAS  Google Scholar 

  • Frezza M, Centini G, Cammareri G, Le Grazie C, Di Padova C. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy: results of a controlled clinical trial. He-pato-Gastroenterology 37: 122–125, 1990

    Google Scholar 

  • Frezza M, Di Padova C. Multicenter placebo controlled clinical trial of intravenous and oral S-adenosyl-L-methionine (SAMe) in cholestatic patients with liver disease. Abstract. Hepatology 7: 1105, 1987a

    Google Scholar 

  • Frezza M, Pozzato G, Chiesa L, Stramentinoli G, Di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology 4: 274–278, 1984

    Article  PubMed  CAS  Google Scholar 

  • Frezza M, Pozzato G, Pison G, et al. S-adenosylmethionine counteracts oral contraceptive hepatotoxicity in women. American Journal of the Medical Sciences 30: 234–238, 1987b

    Article  Google Scholar 

  • Fricker G, Landmann L, Meier PJ. Ethinylestradiol (EE)-induced structural and functional alterations of rat liver plasma membranes and their reversal by S-adenosylmethionine (SAMe) in vitro. Abstract. Hepatology 8: 1224, 1988

    Google Scholar 

  • Ghent CN. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. American Journal of Medicine 82: 117–118, 1987

    CAS  Google Scholar 

  • Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstetrics and Gynecology 61: 581–587, 1983

    PubMed  CAS  Google Scholar 

  • Hirata F, Axelrod J. Phospholipid methylation and biochemical signal transmission. Science 209: 1082–1090, 1980

    Article  PubMed  CAS  Google Scholar 

  • Johnston WG, Basken TF. Obstetric cholestasis: a 14-year review. American Journal of Obstetrics and Gynecology 133: 299–301, 1979

    PubMed  CAS  Google Scholar 

  • Kagan BL, Sultzer D, Rosenlight N, Gerner RH. Oral S-adenosyl-L-methionine in depression: a double-blind, placebo-controlled trial. American Journal of Psychiatry 447: 591–595, 1990

    Google Scholar 

  • Kreek MJ. Female sex steroids and cholestasis. Seminars in Liver Diseases 7: 8–23, 1987

    Article  CAS  Google Scholar 

  • Laatikainen T. Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy. American Journal of Obstetrics and Gynecology 132: 501–506, 1978

    PubMed  CAS  Google Scholar 

  • Lafuenti G, Plotti G, Nicolanti G, et al. Valutazione delie modificazioni di parametri clinici e biochimici in gravide con colestasi in terapia con S-adenosyl-L-methionine per os. Giornale Italiano di Ostetricia e Ginecologia 10: 357–361, 1988

    Google Scholar 

  • Larrauri A, Castell JV, Garrido G, Berenguer J, Gomez-Lechon MJ. S-adenosyl-L-methionine reverses ethynylestradiol-induced impairment on taurocholate uptake in primary cultures of rat hepatocytes. Abstract. Gastroenterology 96: 520, 1989

    Google Scholar 

  • Lunzer M, Barnes P, Byth K, et al. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology 91: 825–829, 1986

    PubMed  CAS  Google Scholar 

  • Ostrow JD. Therapeutic amelioration of jaundice: old and new strategies. Hepatology 8: 683–689, 1988

    Article  PubMed  CAS  Google Scholar 

  • Reid R, Ivey KJ, Rencoret RH, Storey B. Fetal complications of obstetric cholestasis. British Medical Journal 1: 870–872, 1976

    Article  PubMed  CAS  Google Scholar 

  • Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology 2: 87–96, 1982

    Article  PubMed  CAS  Google Scholar 

  • Reyes H, Radrigan ME, Gonzalez MC, et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology 93: 584–590, 1987

    PubMed  CAS  Google Scholar 

  • Ribalta J, Reyes H, Gonzalez MC, et al. S-Adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology 13: 1084–1089, 1991

    PubMed  CAS  Google Scholar 

  • Schorr-Lesnick B, Lebovics E, Dworkin B, Rosenthal WS. Liver diseases unique to pregnancy. American Journal of Medicine 86: 659–670, 1991

    CAS  Google Scholar 

  • Schreiber AJ, Simon FR. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology 3: 607–613, 1983

    Article  PubMed  CAS  Google Scholar 

  • Schreiber AJ, Warren G, Sutherland E, Simon FR. S-adenosyl-methionine (SAMe)-induced cytoprotection against bile acid-induced cholestasis. Abstract. Gastroenterology 84: 1395, 1983

    Google Scholar 

  • Steven MM. Pregnancy and liver disease. Gurt 22: 592–614, 1981

    CAS  Google Scholar 

  • Stramentinoli G, Di Padova C, Gualano M, Rovagnati P, Galli-Kienle M. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implications in estrogen metabolism. Gastroenterology 80: 154–158, 1981

    PubMed  CAS  Google Scholar 

  • Vendemiale G, Altomare E, Trizio T, et al. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scandinavian Journal of Gastroenterology 24: 407–415, 1989

    Article  PubMed  CAS  Google Scholar 

  • Vore M. Estrogen cholestasis: membranes, metabolites, or receptors?. Gastroenterology 93: 643–649, 1986

    Google Scholar 

  • Young DS. Implementation of SI units for clinical laboratory data. Annals of Internal Medicine 106: 114–129, 1987

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Catalino, F., Scarponi, S., Cesa, F. et al. Efficacy and Safety of Intravenous S-Adenosyl-L-Methionine Therapy in the Management of Intrahepatic Cholestasis of Pregnancy. Drug Invest 4 (Suppl 4), 78–82 (1992). https://doi.org/10.1007/BF03258367

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03258367

Keywords

Navigation